Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-09

Clinical Trial Update: The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Exenatide to Lantus insulin assessing vascular function in type 2 diabetes; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)
  • Lantus (insulin glargine)

Snippet

Sponsor: Joslin Diabetes Center | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2018-01-09